
Clover Health Investments, Corp.: updates and filings
Price
$4.96
November 13, 2026Market cap $2.5B
What Ploutos Investor adds for Clover Health Investments
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
June 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operations, officer or director changeForm8-K
- Oct 9, 2026Regulation FD disclosureForm8-K
- Sep 25, 2026Officer or director change (amendment)Form8-K/A
- Sep 24, 2026Officer or director changeForm8-K
- Aug 20, 2026Regulation FD disclosureForm8-K
- Aug 7, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 5, 2026Results of operationsForm8-K
- Jul 17, 2026Other material eventsForm8-K
- Jun 18, 2026Other material eventsForm8-K
- Jun 16, 2026Officer or director changeForm8-K
- Jun 12, 2026Shareholder voteForm8-K
- Jun 10, 2026Other material eventsForm8-K
- May 18, 2026Regulation FD disclosureForm8-K
- May 8, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operationsForm8-K
- Apr 28, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 28, 2026Additional annual meeting materialFormDEFA14A
- Apr 28, 2026Annual meeting proxy statementFormDEF 14A
- Apr 1, 2026Officer or director change, other material eventsForm8-K
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 10, 2026Shares registered for employeesFormS-8
- Mar 6, 2026Regulation FD disclosure (amendment)Form8-K/A
- Mar 6, 2026Regulation FD disclosureForm8-K
- Feb 27, 2026Annual reportfor the period to Dec 31, 2025Form10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations, officer or director change | Document |
| Oct 9, 2026 | 8-K | Regulation FD disclosure | Document |
| Sep 25, 2026 | 8-K/A | Officer or director change (amendment) | Document |
| Sep 24, 2026 | 8-K | Officer or director change | Document |
| Aug 20, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 7, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 5, 2026 | 8-K | Results of operations | Document |
| Jul 17, 2026 | 8-K | Other material events | Document |
| Jun 18, 2026 | 8-K | Other material events | Document |
| Jun 16, 2026 | 8-K | Officer or director change | Document |
| Jun 12, 2026 | 8-K | Shareholder vote | Document |
| Jun 10, 2026 | 8-K | Other material events | Document |
| May 18, 2026 | 8-K | Regulation FD disclosure | Document |
| May 8, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
| Apr 28, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 28, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 1, 2026 | 8-K | Officer or director change, other material events | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 10, 2026 | S-8 | Shares registered for employees | Document |
| Mar 6, 2026 | 8-K/A | Regulation FD disclosure (amendment) | Document |
| Mar 6, 2026 | 8-K | Regulation FD disclosure | Document |
| Feb 27, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 31, 2020.
The full analysis
What do Clover Health Investments's filings show?
The filings are where every one of Clover Health Investments's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.